Connect with us

Business

BioNTech surges on COVID-19 vaccine sales forecast – The Australian Financial Review

BioNTech and partner Pfizer signed contracts to deliver some 2.2 billion doses of the two-shot vaccine this year and more than…

Published

on

Article feature image

The technology is also being tested in cancer, in an aim to spur the immune system to fight off tumours. BioNTech has started six new patient trials this year — for a total of 15 experimental drugs in 18 trials — and said it plans to move two more potential…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending